Countries China
Sciwind Biosciences Partners with Verdiva Bio in $2.4 Billion Deal to Advance Global Metabolic Disease Therapies
Hangzhou Sciwind Biosciences Co., a pre-commercial biopharmaceutical company focusing on developing innovative therapies to treat metabolic diseases, ...
January 13, 2025 | News
JW Therapeutics' Carteyva® Secures Breakthrough Therapy Designation in China for Relapsed/Refractory Large B-Cell Lymphoma
W Therapeutics (HKEx: 2126), an independent and innovative biotechnology company focused on developing, manufacturing and commercializing ce...
January 13, 2025 | News
Kelun-Biotech and Harbour BioMed Ink $970 Million Licensing Deal with Windward Bio for Anti-TSLP Antibody
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that the Company and HBM Holdings Limited ("Harbour BioMed") (togeth...
January 13, 2025 | News
MSD’s GARDASIL® Becomes First HPV Vaccine Approved for Males in China
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the National Medical Products Administration (NMPA) of China ...
January 10, 2025 | News
Global Frenzy for TCE Bispecific Antibodies: Billion-Dollar Deals Propel Chinese Biotech to the Forefront
The trading of TCE (T Cell Engager) bispecific antibodies remains hot, and multinational pharmaceutical companies (MNCs) are still placing orders frantical...
January 10, 2025 | News
Biocytogen and Acepodia Join Forces to Advance Precision Oncology with Dual-Payload Bispecific ADCs
Collaboration initiates development of dual-payload bispecific antibody-drug conjugates (BsAD2Cs) Biocytogen’s RenLite® meets Acepodia’s...
January 08, 2025 | News
Dizal’s China-Origin Sunvozertinib Secures FDA Priority Review for EGFR Exon20ins NSCLC
If approved, Sunvozertinib as a single oral drug would offer a convenient and safe treatment option with superior efficacy for NSCLC patients with E...
January 08, 2025 | News
Alebund Pharmaceuticals Secures RMB 550 Million Series C Financing to Advance Innovative Renal Therapies
Alebund Pharmaceuticals ("Alebund" or the "Company"), an integrated biopharmaceutical company focusing on developing innovative therapies for renal di...
January 08, 2025 | News
Asieris Pharmaceuticals Partners with CDC for Investigational Use of APL-1202 in Fatal Free-Living Amoebae Infections
Asieris Pharmaceuticals (Stock Code: 688176.SH), a leading global biopharmaceutical company dedicated to advancing innovative therapies for genitourinary t...
January 07, 2025 | News
Technoderma Medicines Announces Positive Phase 2a Results for TDM-180935 in Atopic Dermatitis
Technoderma Medicines, Inc. ("the Company"), a clinical stage biopharmaceutical company, is pleased to report the Company has completed its Phase 2a clinic...
January 07, 2025 | News
WuXi Biologics Partners with Candid Therapeutics in $925M Deal to Advance Trispecific T-Cell Engagers
WuXi Biologics ("WuXi Bio") (2269. HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced an agreemen...
January 07, 2025 | News
WuXi Biologics to Sell $500M Irish Vaccine Facility to Merck & Co. Amid U.S. Legislative Pressures
WuXi Biologics has announced plans to sell its vaccine manufacturing facility in Dundalk, Ireland, to Merck & Co. for approximately $500 million. This ...
January 06, 2025 | News
Human Metapneumovirus Sparks Concern Across Asia: India Joins Global Vigilance
The detection of Human Metapneumovirus (HMPV) in Karnataka, India, and a rising number of cases across Asia have prompted heightened vigilance among health...
January 06, 2025 | Analysis
Astellas Pharma Announces NMPA Approval of Zolbetuximab in China for Advanced Gastric and GEJ Cancer
Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that the National Medical Products Administration (N...
January 06, 2025 | News
Most Read
- How Innovation Gaps in Biopharma Raise New Safety Concerns
- Smart Implants and the Future of Musculoskeletal Injury Treatment
- How Ethical Gaps in Psychiatry Could Undermine Biopharma Progress
- The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
- Using NLP-Driven Decision Support in Emergency Health Assistance
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
Bio Jobs
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
